Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 6Recurrence 3Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Rituximab 6Polymerase Chain Reaction 6Amplified Fragment Length Polymorphism Analysis 6Gene Expression Profiling 5obinutuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Microarray Analysis 4Immunohistochemistry 4Flow Cytometry 4Therapeutics 3Immunoenzyme Techniques 3Drug Therapy 3tisagenlecleucel 2duvelisib 2Prednisone 2Lenalidomide 2Influenza Vaccines 2Immunologic Techniques 2Echocardiography 2Blood Specimen Collection 2zanubrutinib 1tazemetostat 1relmacabtagene autoleucel 1pomalidomide 1ibritumomab tiuxetan 1deucravacitinib 1Watchful Waiting 1Waiting Lists 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lymphoma, Follicular × pomalidomide × Clear all
NCT07609446 2026-05-27

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

The First Affiliated Hospital of Soochow University

Not yet recruiting
30 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡